{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/92947"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/92947","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Exploring the roles of key lipids in the influenza virus lifecycle","abstract":"The influenza virus is a common respiratory pathogen with the capacity to cause global pandemics affecting millions of people, contributing substantially to overall mortality and morbidity. Thus, considerable research focuses on the prevention and treatment of influenza virus infection. Despite the availability of vaccines, influenza infection continues to be a common illness due to its ability to rapidly mutate and reassort, introducing novel strains. Focusing on host factors that are exploited by the virus could lead to the development of new therapeutics with lower potential for drug resistance and confer universal strain potency. Sphingolipids are a host lipid that is a known influenza target. According to a long-standing hypothesis, cholesterol and sphingolipids form distinct plasma membrane domains, termed lipid rafts, that help recruit newly synthesized influenza components to virus assembly sites for progeny budding. However, the sphingolipid and cholesterol abundance at this bud zone remains a mystery due to the limited means to image these lipids in the plasma membrane without using labels that may alter their distributions or functions. Recently, a high-resolution secondary ion mass spectrometry approach was used to image stable isotope-labeled cholesterol and sphingolipids in the plasma membranes of fibroblast cells with sub-100 nm lateral resolution. These reports established that sphingolipid domains do not have elevated cholesterol levels, calling into question this hypothesis. We use this technique to show for the first time that the influenza virus does not bud from sphingolipid-enriched domains in the plasma membranes of whole cells. Further experiments also revealed the intracellular 3-dimensional distributions of cholesterol and sphingolipids within a cell with high resolution. This new imaging capability will expand our knowledge of the intricate network of these lipids and help shape our understanding of their exploitation during infection. Sphingolipids are key influenza targets, however, this research indicates that they are not targeted at the plasma membrane, specifically, to recruit viral components for budding. We also discuss the role of ceramide, a central sphingolipid in the sphingolipid biosynthesis pathway, in the influenza lifecycle. Our analyses indicate the need for further studies on ceramide as a potential target of the influenza virus through its regulatory enzymes.","abstract_html":"The influenza virus is a common respiratory pathogen with the capacity to cause global pandemics affecting millions of people, contributing substantially to overall mortality and morbidity. Thus, considerable research focuses on the prevention and treatment of influenza virus infection. Despite the availability of vaccines, influenza infection continues to be a common illness due to its ability to rapidly mutate and reassort, introducing novel strains. Focusing on host factors that are exploited by the virus could lead to the development of new therapeutics with lower potential for drug resistance and confer universal strain potency. Sphingolipids are a host lipid that is a known influenza target. According to a long-standing hypothesis, cholesterol and sphingolipids form distinct plasma membrane domains, termed lipid rafts, that help recruit newly synthesized influenza components to virus assembly sites for progeny budding. However, the sphingolipid and cholesterol abundance at this bud zone remains a mystery due to the limited means to image these lipids in the plasma membrane without using labels that may alter their distributions or functions. Recently, a high-resolution secondary ion mass spectrometry approach was used to image stable isotope-labeled cholesterol and sphingolipids in the plasma membranes of fibroblast cells with sub-100 nm lateral resolution. These reports established that sphingolipid domains do not have elevated cholesterol levels, calling into question this hypothesis. We use this technique to show for the first time that the influenza virus does not bud from sphingolipid-enriched domains in the plasma membranes of whole cells. Further experiments also revealed the intracellular 3-dimensional distributions of cholesterol and sphingolipids within a cell with high resolution. This new imaging capability will expand our knowledge of the intricate network of these lipids and help shape our understanding of their exploitation during infection. Sphingolipids are key influenza targets, however, this research indicates that they are not targeted at the plasma membrane, specifically, to recruit viral components for budding. We also discuss the role of ceramide, a central sphingolipid in the sphingolipid biosynthesis pathway, in the influenza lifecycle. Our analyses indicate the need for further studies on ceramide as a potential target of the influenza virus through its regulatory enzymes.","abstract_has_math":false,"creators":["Yeager, Ashley"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Chemical Engineering","degree_department":null,"school":null,"contributors":["Kraft, Mary L.","Harley, Brendan A.","Leckband, Deborah E.","Shisler, Joanna L."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2016,"date_issued":"2016-11-10T18:27:48Z","date_published":"2016-11-10T18:27:48Z","updated_at":"2026-07-22T22:26:35Z","subjects":["influenza virus","sphingolipids","cholesterol","lipid rafts","plasma membrane","high-resolution secondary ion mass spectrometry","isotope-labeling","3-dimensional (3D) imaging","ceramide","neutral sphingomyelinase"],"languages":["en"],"rights":["Copyright 2016 Ashley N. Yeager"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/2142/92947","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Kraft, Mary L.","Harley, Brendan A.","Leckband, Deborah E.","Shisler, Joanna L."]},{"key":"dc:creator","label":"Author","values":["Yeager, Ashley"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2016-11-10T18:27:48Z","2018-11-11T10:15:32Z","2016-07-13","2016-08"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemical Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["influenza virus","sphingolipids","cholesterol","lipid rafts","plasma membrane","high-resolution secondary ion mass spectrometry","isotope-labeling","3-dimensional (3D) imaging","ceramide","neutral sphingomyelinase"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2016 Ashley N. Yeager"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/92947"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["The influenza virus is a common respiratory pathogen with the capacity to cause global pandemics affecting millions of people, contributing substantially to overall mortality and morbidity. Thus, considerable research focuses on the prevention and treatment of influenza virus infection. Despite the availability of vaccines, influenza infection continues to be a common illness due to its ability to rapidly mutate and reassort, introducing novel strains. Focusing on host factors that are exploited by the virus could lead to the development of new therapeutics with lower potential for drug resistance and confer universal strain potency. Sphingolipids are a host lipid that is a known influenza target. According to a long-standing hypothesis, cholesterol and sphingolipids form distinct plasma membrane domains, termed lipid rafts, that help recruit newly synthesized influenza components to virus assembly sites for progeny budding. However, the sphingolipid and cholesterol abundance at this bud zone remains a mystery due to the limited means to image these lipids in the plasma membrane without using labels that may alter their distributions or functions. Recently, a high-resolution secondary ion mass spectrometry approach was used to image stable isotope-labeled cholesterol and sphingolipids in the plasma membranes of fibroblast cells with sub-100 nm lateral resolution. These reports established that sphingolipid domains do not have elevated cholesterol levels, calling into question this hypothesis. We use this technique to show for the first time that the influenza virus does not bud from sphingolipid-enriched domains in the plasma membranes of whole cells. Further experiments also revealed the intracellular 3-dimensional distributions of cholesterol and sphingolipids within a cell with high resolution. This new imaging capability will expand our knowledge of the intricate network of these lipids and help shape our understanding of their exploitation during infection. Sphingolipids are key influenza targets, however, this research indicates that they are not targeted at the plasma membrane, specifically, to recruit viral components for budding. We also discuss the role of ceramide, a central sphingolipid in the sphingolipid biosynthesis pathway, in the influenza lifecycle. Our analyses indicate the need for further studies on ceramide as a potential target of the influenza virus through its regulatory enzymes.","Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2018-08-01","The student, Ashley Yeager, accepted the attached license on 2016-07-12 at 17:49.","The student, Ashley Yeager, submitted this Dissertation for approval on 2016-07-12 at 18:10.","This Dissertation was approved for publication on 2016-07-13 at 09:46.","DSpace SAF Submission Ingestion Package generated from Vireo submission #9907 on 2016-11-10 at 12:20:34","Made available in DSpace on 2016-11-10T18:27:48Z (GMT). No. of bitstreams: 2 YEAGER-DISSERTATION-2016.pdf: 3417813 bytes, checksum: b9cba0c1e39b6f274e010890043192df (MD5) LICENSE.txt: 4210 bytes, checksum: f7c3d7f414a855c7d895e5fa521f7724 (MD5) Previous issue date: 2016-07-13","Embargo set by: Seth Robbins for item 95367 Lift date: 2018-11-10T18:28:02Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Limited Restriction Lifted for Item 95367 on 2018-11-11T10:15:32Z."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Exploring the roles of key lipids in the influenza virus lifecycle"]}]}],"canonical_facts":{"dc:contributor":["Kraft, Mary L.","Harley, Brendan A.","Leckband, Deborah E.","Shisler, Joanna L."],"dc:creator":["Yeager, Ashley"],"dc:date":["2016-11-10T18:27:48Z","2018-11-11T10:15:32Z","2016-07-13","2016-08"],"dc:description":["The influenza virus is a common respiratory pathogen with the capacity to cause global pandemics affecting millions of people, contributing substantially to overall mortality and morbidity. Thus, considerable research focuses on the prevention and treatment of influenza virus infection. Despite the availability of vaccines, influenza infection continues to be a common illness due to its ability to rapidly mutate and reassort, introducing novel strains. Focusing on host factors that are exploited by the virus could lead to the development of new therapeutics with lower potential for drug resistance and confer universal strain potency. Sphingolipids are a host lipid that is a known influenza target. According to a long-standing hypothesis, cholesterol and sphingolipids form distinct plasma membrane domains, termed lipid rafts, that help recruit newly synthesized influenza components to virus assembly sites for progeny budding. However, the sphingolipid and cholesterol abundance at this bud zone remains a mystery due to the limited means to image these lipids in the plasma membrane without using labels that may alter their distributions or functions. Recently, a high-resolution secondary ion mass spectrometry approach was used to image stable isotope-labeled cholesterol and sphingolipids in the plasma membranes of fibroblast cells with sub-100 nm lateral resolution. These reports established that sphingolipid domains do not have elevated cholesterol levels, calling into question this hypothesis. We use this technique to show for the first time that the influenza virus does not bud from sphingolipid-enriched domains in the plasma membranes of whole cells. Further experiments also revealed the intracellular 3-dimensional distributions of cholesterol and sphingolipids within a cell with high resolution. This new imaging capability will expand our knowledge of the intricate network of these lipids and help shape our understanding of their exploitation during infection. Sphingolipids are key influenza targets, however, this research indicates that they are not targeted at the plasma membrane, specifically, to recruit viral components for budding. We also discuss the role of ceramide, a central sphingolipid in the sphingolipid biosynthesis pathway, in the influenza lifecycle. Our analyses indicate the need for further studies on ceramide as a potential target of the influenza virus through its regulatory enzymes.","Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2018-08-01","The student, Ashley Yeager, accepted the attached license on 2016-07-12 at 17:49.","The student, Ashley Yeager, submitted this Dissertation for approval on 2016-07-12 at 18:10.","This Dissertation was approved for publication on 2016-07-13 at 09:46.","DSpace SAF Submission Ingestion Package generated from Vireo submission #9907 on 2016-11-10 at 12:20:34","Made available in DSpace on 2016-11-10T18:27:48Z (GMT). No. of bitstreams: 2 YEAGER-DISSERTATION-2016.pdf: 3417813 bytes, checksum: b9cba0c1e39b6f274e010890043192df (MD5) LICENSE.txt: 4210 bytes, checksum: f7c3d7f414a855c7d895e5fa521f7724 (MD5) Previous issue date: 2016-07-13","Embargo set by: Seth Robbins for item 95367 Lift date: 2018-11-10T18:28:02Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Limited Restriction Lifted for Item 95367 on 2018-11-11T10:15:32Z."],"dc:format":["application/pdf"],"dc:identifier":["http://hdl.handle.net/2142/92947"],"dc:language":["en"],"dc:rights":["Copyright 2016 Ashley N. Yeager"],"dc:subject":["influenza virus","sphingolipids","cholesterol","lipid rafts","plasma membrane","high-resolution secondary ion mass spectrometry","isotope-labeling","3-dimensional (3D) imaging","ceramide","neutral sphingomyelinase"],"dc:title":["Exploring the roles of key lipids in the influenza virus lifecycle"],"dc:type":["text"],"thesis:degree_discipline":["Chemical Engineering"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:26:35Z"}